Lyka Labs Limited , a prominent pharmaceutical company, has made several significant announcements following its recent Board of Directors meeting. The company has released its unaudited financial results for the quarter ended June 30, 2025, and disclosed important changes in its management structure and internal audit processes.

Financial Results

The Board of Directors has approved and taken on record the unaudited financial results for the first quarter of the fiscal year 2025-26. These results, both standalone and consolidated, have been reviewed and are accompanied by a Limited Review Report. The detailed financial figures are available in the annexures of the company's official communication.

Management Changes

Resignation of Company Secretary

In a significant development, Mr. Shekhar R Singh, the Company Secretary and Compliance Officer of Lyka Labs, has tendered his resignation. Mr. Singh cited the pursuit of alternative career opportunities outside the organization as the reason for his departure.

Key points regarding Mr. Singh's resignation:

• The resignation was initially effective from the close of business hours on July 30, 2025.
• Mr. Singh has committed to continuing his responsibilities, including those related to the upcoming 46th Annual General Meeting (AGM).
• He will ensure a smooth and structured handover before his exit.
• The Board has accepted his resignation, effective from the close of business hours on August 1, 2025.
• The company has expressed appreciation for Mr. Singh's valuable contributions during his tenure.

Appointment of New Internal Auditor

In another strategic move, Lyka Labs has appointed a new internal auditor for the financial year 2025-26.

Details of the appointment:

• Firm: Sudit K Parekh & Co. LLP, Chartered Accountants
• Firm Registration Number: 110512W/ W100378
• Appointment Date: August 1, 2025
• Term: For the financial year 2025-26

Sudit K Parekh & Co. LLP is a Mumbai-based firm of practicing Chartered Accountants. The firm is known for offering a wide spectrum of services to its clientele and has significant experience in handling internal audit assignments. With highly qualified partners and an experienced team, the firm is well-positioned to support Lyka Labs in its internal audit functions.

Conclusion

These announcements reflect Lyka Labs' commitment to transparency and corporate governance. The company's proactive approach in managing leadership transitions and strengthening its internal audit processes demonstrates its focus on maintaining robust financial and operational standards. Investors and stakeholders will be keenly watching how these changes impact the company's performance in the coming quarters.

Lyka Labs Limited has made several significant announcements following its recent Board of Directors meeting. The pharmaceutical company has approved its quarterly results and revealed important changes in its management structure.

Quarterly Financial Results Approved

The Board of Directors of Lyka Labs has approved the unaudited financial results for the quarter ended June 30, 2025. These results encompass both standalone and consolidated statements, providing a comprehensive view of the company's financial performance for the first quarter of the fiscal year 2025-26.

Company Secretary Resignation

In a notable management change, Mr. Shekhar R Singh has resigned from his position as Company Secretary and Compliance Officer of Lyka Labs. The resignation, which was tendered on July 1, 2025, citing pursuit of alternative career opportunities, will be effective from the close of business hours on August 1, 2025.

Mr. Singh has committed to fulfilling his responsibilities, including those related to the upcoming 46th Annual General Meeting (AGM), and ensuring a smooth transition before his departure. The Board has acknowledged Mr. Singh's contributions during his tenure with the company.

Appointment of Internal Auditor

In a move to strengthen its internal audit function, Lyka Labs has appointed Sudit K Parekh & Co. LLP as the Internal Auditor for the financial year 2025-26. The Mumbai-based chartered accountancy firm, with registration number 110512W/W100378, brings extensive experience in internal audit assignments to the role.

Board Meeting Details

The Board meeting, which commenced at 11:10 am and concluded at 12:25 pm on August 1, 2025, addressed these key matters. The company has duly informed the stock exchanges of these developments in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

These corporate actions reflect Lyka Labs' commitment to maintaining transparent communication with its stakeholders and ensuring robust corporate governance practices. Investors and market observers will likely keep a close watch on how these changes impact the company's operations and performance in the coming quarters.